Are Tough Times Ahead for Countries Graduating from Foreign Aid?

During the next few years, over a dozen middle-income countries are likely to transition away from multilateral concessional assistance—that is, grants and loans that offer flexible or lenient terms for repayment—including support from International Development Association (IDA) and Gavi, the Vaccine Alliance. There are good reasons to worry these countries, including Nigeria and Pakistan, will find the transition tough. Despite being middle-income economies, many of them still have high rates of child and maternal mortality, weak health systems, and large shares of the population living in poverty.

Are these countries are more vulnerable and less ready to transition than countries that previously graduated? And, if they are, should multilateral agencies adjust their transition policies?

Read the full analysis.

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

COVAX Application Materials for AMC Eligible Economies Now Available

The COVAX Facility released the application and guidance documents (“application package”) for eligible economies to (i) confirm participation in the COVAX Facility and (ii) request support as part of COVAX. This comprises COVID-19 vaccines, as well as Cold Chain Equipment and Technical Assistance needed to prepare for the delivery of COVID-19 vaccines.  All 92 AMC Eligible … Read More

COVID-19: Gavi steps up response to pandemic

Gavi, the Vaccine Alliance, will provide US$ 29 million in urgent initial funding to 13 lower-income countries to support their response to COVID-19, helping them to protect health care workers with personal protective equipment (PPE), perform vital surveillance and training, and fund diagnostic tests. There are further requests or interest from 21 countries, meaning more … Read More

Center for Global Development – Global Immunization and Gavi: Five Priorities for the Next Five Years

Below is an excerpt from the Center for Global Development’s overview note.  Child vaccination remains among the most cost-effective uses of public and aid monies.[1] In a highly contested funding environment where priorities must be set for the allocation of scarce concessional resources, investment in expanding the availability and coverage of cost-effective vaccination must come … Read More